Greenyn Biotechnology Co., Ltd (TPEX:6846)
Taiwan · Delayed Price · Currency is TWD 71.00
-0.10 (-0.14%)
Apr 20, 2026, 12:22 PM CST
Greenyn Biotechnology Market Cap
Greenyn Biotechnology has a market cap or net worth of 1.92 billion as of April 20, 2026. Its market cap has decreased by -18.08% in one year.
Market Cap
1.92B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
71.00
Market Cap Chart
Since April 19, 2022, Greenyn Biotechnology's market cap has decreased from 2.03B to 1.92B, a decrease of -5.42%. That is a compound annual growth rate of -1.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.92B | -3.27% |
| Dec 31, 2025 | 1.98B | -8.66% |
| Dec 31, 2024 | 2.17B | 2.47% |
| Dec 29, 2023 | 2.12B | 6.41% |
| Dec 30, 2022 | 1.99B | -1.69% |
| Apr 19, 2022 | 2.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlycoNex Incorporation | 2.58B |
| 3D Global Biotech | 2.48B |
| G&E Herbal Biotechnology | 2.38B |
| Chunghwa Chemical Synthesis & Biotech | 2.26B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.16B |
| Sunny Pharmtech | 2.13B |
| Synbio Tech | 2.04B |
| TaiRx | 1.99B |